Mycoplasma contamination of leukemic cell lines alters protein expression determined by reverse phase protein arrays

被引:0
作者
Fieke W. Hoff
Chenyue W. Hu
Amina A. Qutub
Yihua Qiu
Elizabeth Graver
Giang Hoang
Manasi Chauhan
Eveline S. J. M. de Bont
Steven M. Kornblau
机构
[1] University of Groningen,Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen
[2] Rice University,Department of Bioengineering
[3] The University of Texas MD Anderson Cancer Center,Department of Leukemia
来源
Cytotechnology | 2018年 / 70卷
关键词
Mycoplasma; RPPA; Cell lines; Proteomics;
D O I
暂无
中图分类号
学科分类号
摘要
Mycoplasma contamination is a major problem in cell culturing, potentially altering the results of cell line-based experiments in largely uncharacterized ways. To define the consequences of mycoplasma infection at the level of protein expression we utilized the reverse phase protein array technology to analyze the expression of 235 proteins in mycoplasma infected, uninfected post treatment, and never-infected leukemic cell lines. Overall, protein profiles of cultured cells remained relatively stable after mycoplasma infection. However, paired comparisons for individual proteins identified that 18.7% of the proteins significantly changed between the infected and the never-infected cell line samples, and that 14.0% of the proteins significantly altered between the infected and the post treatment samples. Six percent of the proteins were affected in the post treatment samples compared to the never-infected samples, and 7.2% compared to treated cells that had never had mycoplasma infection before. Proteins that were significantly altered in the infected cells were enriched for apoptotic signaling processes and auto-phosphorylation, suggesting an increased cellular stress and a decreased growth rate. In conclusion, this study shows that mycoplasma infection of leukemic cell lines alters the proteins expression levels, potentially confounding experimental results. This reinforces the need for regular testing of mycoplasma.
引用
收藏
页码:1529 / 1535
页数:6
相关论文
共 49 条
  • [31] Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli
    Steube, KG
    Meyer, C
    Drexler, HG
    LEUKEMIA RESEARCH, 1999, 23 (09) : 843 - 849
  • [32] Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC), cell lines as platform for cancer proteomics and biomarker discovery
    Ummanni, Ramesh
    Mannsperger, Heiko A.
    Sonntag, Johanna
    Oswald, Marcus
    Sharma, Ashwini K.
    Koenig, Rainer
    Korf, Ulrike
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (05): : 950 - 959
  • [33] Distinctive morphological and gene/protein expression signatures during myogenesis in novel cell lines from extraocular and hindlimb muscle
    Porter, JD
    Israel, S
    Gong, BD
    Merriam, AP
    Feuerman, J
    Khanna, S
    Kaminski, HJ
    PHYSIOLOGICAL GENOMICS, 2006, 24 (03) : 264 - 275
  • [34] A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
    Li, Jun
    Liu, Wei
    Mojumdar, Kamalika
    Kim, Hong
    Zhou, Zhicheng
    Ju, Zhenlin
    Kumar, Shwetha V.
    Ng, Patrick Kwok-Shing
    Chen, Han
    Davies, Michael A.
    Lu, Yiling
    Akbani, Rehan
    Mills, Gordon B.
    Liang, Han
    NATURE CANCER, 2024, 5 (10) : 1579 - 1595
  • [35] Decabrominated diphenyl ether (BDE-209) and/or BDE-47 exposure alters protein expression in purified neural stem/progenitor cells determined by proteomics analysis
    Song, Jie
    Li, Zhi-hua
    He, Yu-Tian
    Liu, Chuan-Xin
    Sun, Bin
    Zhang, Chun-Fang
    Zeng, Jie
    Du, Pei-Li
    Zhang, Hui-li
    Yu, Yan-hong
    Chen, Dun-Jin
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2014, 33 : 8 - 14
  • [36] A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
    Kimberly C Wiegand
    Bryan T Hennessy
    Samuel Leung
    Yemin Wang
    Zhenlin Ju
    Mollianne McGahren
    Steve E Kalloger
    Sarah Finlayson
    Katherine Stemke-Hale
    Yiling Lu
    Fan Zhang
    Michael S Anglesio
    Blake Gilks
    Gordon B Mills
    David G Huntsman
    Mark S Carey
    BMC Cancer, 14
  • [37] A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
    Wiegand, Kimberly C.
    Hennessy, Bryan T.
    Leung, Samuel
    Wang, Yemin
    Ju, Zhenlin
    McGahren, Mollianne
    Kalloger, Steve E.
    Finlayson, Sarah
    Stemke-Hale, Katherine
    Lu, Yiling
    Zhang, Fan
    Anglesio, Michael S.
    Gilks, Blake
    Mills, Gordon B.
    Huntsman, David G.
    Carey, Mark S.
    BMC CANCER, 2014, 14
  • [38] Differential p53 protein expression level in human cancer-derived cell lines after estradiol treatment
    Correa, I
    Cerbón, MA
    Salazar, AM
    Solano, JD
    García-Carrancá, A
    Quintero, A
    ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (05) : 455 - 459
  • [39] Comparison of p53 Mutational Status with mRNA and Protein Expression in a Panel of 24 Human Breast Carcinoma Cell Lines
    Nicole Concin
    Christa Zeillinger
    Dan Tong
    Margit Stimpfl
    Margit König
    Dieter Printz
    Felix Stonek
    Christian Schneeberger
    Lukas Hefler
    Christian Kainz
    Sepp Leodolter
    Oskar A. Haas
    Robert Zeillinger
    Breast Cancer Research and Treatment, 2003, 79 : 37 - 46
  • [40] Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines
    Concin, N
    Zeillinger, C
    Tong, D
    Stimpfl, M
    König, M
    Printz, D
    Stonek, F
    Schneeberger, C
    Hefler, L
    Kainz, C
    Leodolter, S
    Haas, OA
    Zeillinger, R
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (01) : 37 - 46